tiprankstipranks
Precision Optics Corporation (POCI)
NASDAQ:POCI
US Market
Want to see POCI full AI Analyst Report?

Precision Optics Corporation (POCI) Price & Analysis

18 Followers

POCI Stock Chart & Stats

$4.21
-$0.09(-1.91%)
At close: 4:00 PM EST
$4.21
-$0.09(-1.91%)

Bulls Say, Bears Say

Bulls Say
Revenue Growth & Raised GuidanceManagement raising FY2026 revenue guidance materially signals durable demand expansion and confidence in program conversion. Sustained revenue acceleration supports operational leverage, justifies incremental investment in capacity and R&D, and increases the odds of moving to sustained profitability over months.
Gross Margin & Yield ImprovementsRapid gross margin recovery reflects repeatable manufacturing and yield gains across programs. Higher and improving yields reduce unit costs, enabling more durable margin expansion as volumes scale, which is a structural driver of eventual positive operating leverage if yield targets and throughput are sustained.
Strengthened Liquidity Via FinancingA strengthened cash position materially reduces near-term funding risk and gives management runway to invest in production scale, yield improvements, and program qualification. This financing supports strategic execution over the next 6–12 months without immediate dilutive emergency financings.
Bears Say
Negative Cash Flow & ProfitabilityDespite improving quarterly EBITDA, the business remains cash negative on a TTM basis, consuming cash to fund operations and growth. Continued negative free cash flow increases reliance on capital markets or debt until sustained positive operating cash generation is achieved, creating medium-term funding risk.
Customer Concentration & Pullback RiskHeavy revenue dependence on a few customers, notably a top aerospace account, creates structural top-line volatility. A customer-requested 15%–20% production slowdown materially risks near-term revenue and complicates capacity planning and margin forecasting if similar concentration persists.
Facility & Production ConstraintsFragmented, partially unmodernized production infrastructure is a lasting operational constraint that can limit throughput, raise per-unit costs, and slow new program ramp. Capital and execution are required to consolidate and modernize facilities to sustain margin gains and support multi-program scale.

Precision Optics Corporation News

POCI FAQ

What was Precision Optics Corporation’s price range in the past 12 months?
Precision Optics Corporation lowest stock price was $3.55 and its highest was $6.04 in the past 12 months.
    What is Precision Optics Corporation’s market cap?
    Precision Optics Corporation’s market cap is $53.96M.
      When is Precision Optics Corporation’s upcoming earnings report date?
      Precision Optics Corporation’s upcoming earnings report date is Sep 24, 2026 which is in 122 days.
        How were Precision Optics Corporation’s earnings last quarter?
        Precision Optics Corporation released its earnings results on May 13, 2026. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
          Is Precision Optics Corporation overvalued?
          According to Wall Street analysts Precision Optics Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Precision Optics Corporation pay dividends?
            Precision Optics Corporation does not currently pay dividends.
            What is Precision Optics Corporation’s EPS estimate?
            Precision Optics Corporation’s EPS estimate is -0.06.
              How many shares outstanding does Precision Optics Corporation have?
              Precision Optics Corporation has 10,944,869 shares outstanding.
                What happened to Precision Optics Corporation’s price movement after its last earnings report?
                Precision Optics Corporation reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.913%.
                  Which hedge fund is a major shareholder of Precision Optics Corporation?
                  Currently, no hedge funds are holding shares in POCI
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Precision Optics Corporation Stock Smart Score

                    Company Description

                    Precision Optics Corporation

                    Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

                    Precision Optics Corporation (POCI) Earnings & Revenues

                    POCI Earnings Call

                    Q3 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call communicated strong operational momentum and important financial inflection points: record revenue, materially improved gross margins, and positive adjusted EBITDA in Q3, supported by manufacturing yield gains, Ross Optical growth and a reinforced cash position from a $10M offering. Management increased full-year revenue guidance and outlined a robust pipeline with multiple programs expected to enter production. Key near-term risks include a customer-requested aerospace production slowdown (estimated 15%–20% pullback in early FY2027), remaining yield improvements needed on the cystoscope line, and facility modernization requirements. On balance, the positive operational and financial progress significantly outweighs the contained challenges, indicating constructive near-term trajectory toward sustained profitability.View all POCI earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Retractable Technologies
                    Milestone Scientific
                    Femasys
                    NexGel Inc

                    Ownership Overview

                    5.27%17.49%29.39%45.94%
                    29.39% Other Institutional Investors
                    45.94% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks